9-137882854-C-G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong

The NM_000718.4(CACNA1B):​c.501C>G​(p.Asn167Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

CACNA1B
NM_000718.4 missense

Scores

8
3
6

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.13

Publications

36 publications found
Variant links:
Genes affected
CACNA1B (HGNC:1389): (calcium voltage-gated channel subunit alpha1 B) The protein encoded by this gene is the pore-forming subunit of an N-type voltage-dependent calcium channel, which controls neurotransmitter release from neurons. The encoded protein forms a complex with alpha-2, beta, and delta subunits to form the high-voltage activated channel. This channel is sensitive to omega-conotoxin-GVIA and omega-agatoxin-IIIA but insensitive to dihydropyridines. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
CACNA1B Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • complex neurodevelopmental disorder with motor features
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0038129091).
BP6
Variant 9-137882854-C-G is Benign according to our data. Variant chr9-137882854-C-G is described in ClinVar as Benign. ClinVar VariationId is 802555.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000718.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1B
NM_000718.4
MANE Select
c.501C>Gp.Asn167Lys
missense
Exon 3 of 47NP_000709.1
CACNA1B
NM_001243812.2
c.501C>Gp.Asn167Lys
missense
Exon 3 of 47NP_001230741.1
CACNA1B-AS2
NR_121583.1
n.2674G>C
non_coding_transcript_exon
Exon 2 of 4

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1B
ENST00000371372.6
TSL:5 MANE Select
c.501C>Gp.Asn167Lys
missense
Exon 3 of 47ENSP00000360423.1
CACNA1B
ENST00000371357.5
TSL:5
c.501C>Gp.Asn167Lys
missense
Exon 3 of 46ENSP00000360408.1
CACNA1B
ENST00000371363.5
TSL:5
c.501C>Gp.Asn167Lys
missense
Exon 3 of 46ENSP00000360414.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.500
AC:
124620
AN:
249262
AF XY:
0.500
show subpopulations
Gnomad AFR exome
AF:
0.500
Gnomad AMR exome
AF:
0.500
Gnomad ASJ exome
AF:
0.500
Gnomad EAS exome
AF:
0.499
Gnomad FIN exome
AF:
0.500
Gnomad NFE exome
AF:
0.500
Gnomad OTH exome
AF:
0.500
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.245
Hom.:
0
ExAC
AF:
0.499
AC:
60416

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 30, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.040
CADD
Benign
5.3
DANN
Benign
0.90
DEOGEN2
Pathogenic
0.96
D
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0038
T
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
5.0
H
PhyloP100
-1.1
PrimateAI
Uncertain
0.77
T
PROVEAN
Pathogenic
-5.4
D
REVEL
Pathogenic
0.75
Sift
Uncertain
0.010
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.53
MutPred
0.52
Gain of methylation at N167 (P = 0.0022)
MPC
1.0
ClinPred
0.15
T
GERP RS
-4.7
Varity_R
0.93
gMVP
1.0
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4422842; hg19: chr9-140777306; COSMIC: COSV53112319; API